Cellular and humoral responses to measles in subacute sclerosing panencephalitis.

PubWeight™: 1.44‹?› | Rank: Top 5%

🔗 View Article (PMID 4178001)

Published in Lancet on January 11, 1969

Authors

M Saunders, M E Chambers, M Knowles, E A Caspary, D Gardner-Medwin, P Walker

Articles by these authors

Good behavior game: effects of individual contingencies for group consequences on disruptive behavior in a classroom. J Appl Behav Anal (1969) 11.76

Lymphocyte sensitisation: an in-vitro test for cancer? Lancet (1970) 8.23

Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell (1992) 5.87

Lymphocyte transformation in vitro measured by tritiated thymidine uptake. I. Lymphocyte culture techniques. Int Arch Allergy Appl Immunol (1970) 5.67

Specific lymphocyte sensitization in cancer: is there a common antigen in human malignant neoplasia? Br Med J (1971) 5.53

Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. N Engl J Med (1981) 3.85

Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis. J Pediatr (1997) 3.38

Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity. EMBO J (1994) 3.00

Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids. Proc Natl Acad Sci U S A (1993) 2.96

Circulating sensitised lymphocytes in Graves' disease. Observations on its pathogenesis. Lancet (1970) 2.73

Relative ion permeability of normal and cystic fibrosis nasal epithelium. J Clin Invest (1983) 2.72

Preferential deletion of exons in Duchenne and Becker muscular dystrophies. Nature (1987) 2.67

Genotypic and phenotypic characterization of human immunodeficiency virus type 1 variants isolated from patients treated with the protease inhibitor nelfinavir. Antimicrob Agents Chemother (1998) 2.67

Correlation of the highest-energy cosmic rays with nearby extragalactic objects. Science (2007) 2.57

Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros (2008) 2.56

High-dose cytarabine (24 g/m2) in combination with idarubicin (HiDAC-3) results in high first-cycle response with limited gastrointestinal toxicity in adult acute myeloid leukaemia. Intern Med J (2013) 2.53

Promoter context- and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors. Cell (1992) 2.50

All-trans and 9-cis retinoic acid induction of CRABPII transcription is mediated by RAR-RXR heterodimers bound to DR1 and DR2 repeated motifs. Cell (1992) 2.49

Lymphocyte sensitization in advanced malignant disease: a study of serum lymphocyte depressive factor. Br J Cancer (1972) 2.46

Sequence homologies in the region preceding the transcription initiation site of the liver estrogen-responsive vitellogenin and apo-VLDLII genes. Nucleic Acids Res (1984) 2.42

Dominant negative stat3 mutant inhibits interleukin-6-induced Jak-STAT signal transduction. J Biol Chem (1996) 2.39

A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol (1997) 2.35

Guidelines for resection of colorectal cancer liver metastases. Gut (2006) 2.35

Anxieties in women undergoing colposcopy. Br J Obstet Gynaecol (1990) 2.24

Colposcopic assessment of the accuracy of cervical cytology screening. Br Med J (Clin Res Ed) (1988) 2.22

Atlanto-axial subluxation and cervical myelopathy in rheumatoid arthritis. Q J Med (1971) 2.20

Sensitization of blood lymphocytes to possible antigens in neurological disease. Eur Neurol (1970) 2.19

Mortality experience of male workers at a UK tin smelter. Occup Med (Lond) (2005) 2.10

Myocardial infarction associated with the administration of intravenous ephedrine and metaraminol for spinal-induced hypotension. Anaesthesia (2009) 2.06

Demonstration of sensitized lymphocytes in blood. J Clin Pathol (1971) 2.04

Pre- and post-synaptic abnormalities associated with impaired neuromuscular transmission in a group of patients with 'limb-girdle myasthenia'. Brain (2006) 1.95

What is the optimum treatment of cervical premalignancy? Br J Obstet Gynaecol (1982) 1.94

Export from the endoplasmic reticulum represents the limiting step in the maturation and cell surface expression of the human delta opioid receptor. J Biol Chem (2000) 1.91

The accuracy of repeat cytology in women with mildly dyskaryotic smears. Br J Obstet Gynaecol (1989) 1.90

Lymphocyte-antigen interaction in electrophoretic mobility test for cellular sensitization. Nat New Biol (1971) 1.90

Identification of estrogen-responsive DNA sequences by transient expression experiments in a human breast cancer cell line. Nucleic Acids Res (1986) 1.89

Impact of introduction of colposcopy to a district general hospital. Br Med J (Clin Res Ed) (1984) 1.87

The syndrome of Karl Ludwig Kahlbaum. J Neurol Neurosurg Psychiatry (1986) 1.86

Clinical features and classification of the muscular dystrophies. Br Med Bull (1980) 1.82

Geographic variation in the onset of decline of ischemic heart disease mortality in the United States. Am J Public Health (1986) 1.77

Clinical features and molecular analysis of the alpha thalassemia/mental retardation syndromes. II. Cases without detectable abnormality of the alpha globin complex. Am J Hum Genet (1990) 1.76

The prevalence of specific arithmetic difficulties and specific reading difficulties in 9- to 10-year-old boys and girls. J Child Psychol Psychiatry (1994) 1.72

A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family. Hum Mol Genet (2001) 1.70

Newly synthesized human delta opioid receptors retained in the endoplasmic reticulum are retrotranslocated to the cytosol, deglycosylated, ubiquitinated, and degraded by the proteasome. J Biol Chem (2000) 1.69

Reduction of unwanted submental fat with ATX-101 (deoxycholic acid), an adipocytolytic injectable treatment: results from a phase III, randomized, placebo-controlled study. Br J Dermatol (2014) 1.69

Fulminant ulcerative colitis in pregnancy. Am J Gastroenterol (1994) 1.69

Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein. Science (1992) 1.69

Expression of the novel galanin receptor subtype GALR2 in the adult rat CNS: distinct distribution from GALR1. J Comp Neurol (1999) 1.60

Intravenous aminophylline in patients admitted to hospital with non-acidotic exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Thorax (2005) 1.59

Platelet stickiness in multiple sclerosis. Lancet (1965) 1.58

Benign spinal muscular atrophy arising in childhood and adolescence. J Neurol Sci (1968) 1.57

Immobilisation hypercalcaemia complicating polyneuropathy in adolescent boys. J Neurol Neurosurg Psychiatry (1984) 1.56

Sleep apnoea related hypoxia is associated with cognitive disturbances in patients with tetraplegia. Spinal Cord (1998) 1.55

The effect of cervical mobility on the natural history of cervical spondylotic myelopathy. J Neurol Neurosurg Psychiatry (1984) 1.55

Neurologic profiles of infants and children after perinatal stroke. Pediatr Neurol (1994) 1.54

Recommendations for the classification of diseases as CFTR-related disorders. J Cyst Fibros (2011) 1.54

Heterogeneity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy. Acta Neuropathol (1990) 1.52

Bioelectric properties and ion flow across excised human bronchi. J Appl Physiol Respir Environ Exerc Physiol (1984) 1.52

The shifting stroke belt. Changes in the geographic pattern of stroke mortality in the United States, 1962 to 1988. Stroke (1995) 1.51

The alteration of serum potassium level during sample transit. Practitioner (1989) 1.51

Studies of the carrier state in the Duchenne type of muscular dystrophy. 2. Quantitative electromyography as a method of carrier detection. J Neurol Neurosurg Psychiatry (1968) 1.50

Prevalence and incidence of Becker muscular dystrophy. Lancet (1991) 1.50

Lymphocyte stimulation with muscle homogenate in polymyositis and other muscle-wasting disorders. J Neurol Neurosurg Psychiatry (1969) 1.49

The macrophage electrophoretic migration (MEM) test for lymphocyte sensitization. A study of the kinetics. Clin Exp Immunol (1973) 1.49

Total condylar knee replacment: preliminary report. Clin Orthop Relat Res (1976) 1.49

"Spontaneous" lymphocyte reactivity in the presence of virus infection. Lancet (1972) 1.48

Dystrophin in skeletal muscle. II. Immunoreactivity in patients with Xp21 muscular dystrophy. J Neurol Sci (1989) 1.48

In vivo validation of whole body composition estimates from dual-energy X-ray absorptiometry. J Appl Physiol (1985) (1997) 1.46

Lymphocyte transformation in multiple sclerosis. Inhibition of unstimulated thymidine uptake by a serum factor. Lancet (1968) 1.46

Retinoic acid receptor gamma: specific immunodetection and phosphorylation. J Cell Biol (1991) 1.44

Proficiency testing of clinical microbiology laboratories using modified decontamination procedures for detection of nontuberculous mycobacteria in sputum samples from cystic fibrosis patients. The Nontuberculous Mycobacteria in Cystic Fibrosis Study Group. J Clin Microbiol (1997) 1.44

Two cases of cryptococcal meningitis, one treated with 5-fluorocytosine. Br Med J (1969) 1.43

Photodynamic therapy in the canine prostate using motexafin lutetium. Clin Cancer Res (2001) 1.43

The receptor for the orexigenic peptide melanin-concentrating hormone is a G-protein-coupled receptor. Nat Cell Biol (1999) 1.43

Lymphocyte sensitization to basic protein of brain in malignant neoplasia: experiments with serotonin and related compounds. Nature (1971) 1.41

The mechanism of antigen-induced electrophoretic mobility reduction of guinea-pig macrophages. Clin Exp Immunol (1972) 1.40

Diaphragmatic paralysis due to spinal muscular atrophy. An unrecognised cause of respiratory failure in infancy? Arch Dis Child (1985) 1.40

Lymphocyte sensitization in sarcoidosis. Br Med J (1971) 1.39

Medical litigation in Ireland. Lancet (2001) 1.39

Persistent involuntary movements after treatment with flupenthixol. Br Med J (Clin Res Ed) (1981) 1.39

Sodium salicylate inhibits cyclo-oxygenase-2 activity independently of transcription factor (nuclear factor kappaB) activation: role of arachidonic acid. Mol Pharmacol (1997) 1.38

Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy. A randomized, placebo-controlled, double-blind study. Arch Intern Med (1991) 1.38

Purification and properties of a lymphocyte inhibition factor from human serum. Clin Exp Immunol (1973) 1.37

Serotonin as a developmental signal. Behav Brain Res (1996) 1.37

The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. II. Correlation of phenotype with genetic and protein abnormalities. J Neurol (1993) 1.37

Lymphocyte trnsformation induced by encephalitogenic factor in multiple sclerosis and other neurological diseases. Lancet (1968) 1.36

Immunological aspects of polymyositis. The in vitro activity of lymphocytes on incubation with muscle antigen and with muscle cultures. Q J Med (1971) 1.35

A common tumour specific antigen. I. Restriction in vivo to malignant neoplastic tissue. Br J Cancer (1973) 1.34

Biotin-response organicaciduria. Multiple carboxylase defects and complementation studies with propionicacidemia in cultured fibroblasts. J Clin Invest (1979) 1.33

Intravenous methylprednisolone for multiple sclerosis in relapse. J Neurol Neurosurg Psychiatry (1985) 1.31

Electrical properties of muscle fibre membranes in man. J Neurol Neurosurg Psychiatry (1968) 1.30

Immunological aspects of systemic sclerosis in vitro activity of lymphocytes from patients with the disorder. Br J Dermatol (1971) 1.30

Life events stress and psychosocial factors in men with peptic ulcer disease. A multidimensional case-controlled study. Gastroenterology (1986) 1.29

Lymphocyte transformation in the Guillain-Barré syndrome. Lancet (1969) 1.29

Who gets radiotherapy? Health Trends (1990) 1.28